CA2415225A1 - Composition and method for enhancing elasticity of tissue - Google Patents

Composition and method for enhancing elasticity of tissue Download PDF

Info

Publication number
CA2415225A1
CA2415225A1 CA002415225A CA2415225A CA2415225A1 CA 2415225 A1 CA2415225 A1 CA 2415225A1 CA 002415225 A CA002415225 A CA 002415225A CA 2415225 A CA2415225 A CA 2415225A CA 2415225 A1 CA2415225 A1 CA 2415225A1
Authority
CA
Canada
Prior art keywords
seq
peptide
composition
elastin
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002415225A
Other languages
English (en)
French (fr)
Inventor
Thomas F. Mitts
Lawrence B. Sandberg
Felipe Jimenez Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Connective Tissue Imagineering LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Application filed by Individual filed Critical Individual
Publication of CA2415225A1 publication Critical patent/CA2415225A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002415225A 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue Abandoned CA2415225A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/580,156 2000-05-30
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US09/580,893 2000-05-30
US09/584,001 2000-05-30
US09/580,110 2000-05-30
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
PCT/US2001/017384 WO2001091700A2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Publications (1)

Publication Number Publication Date
CA2415225A1 true CA2415225A1 (en) 2001-12-06

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415225A Abandoned CA2415225A1 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Country Status (7)

Country Link
EP (1) EP1392346A4 (no)
AU (2) AU2001275018B2 (no)
CA (1) CA2415225A1 (no)
IL (1) IL153687A0 (no)
NO (1) NO20030454L (no)
NZ (1) NZ523403A (no)
WO (1) WO2001091700A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
WO2003030860A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 피부의 색소 과다 침착의 치료방법
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (de) * 2002-12-20 2004-07-08 Henkel Kgaa Verfahren zur Bestimmung von Markern humaner Gesichtshaut
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
EP1765280A1 (en) * 2004-06-28 2007-03-28 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
CA2652388A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
WO2008100789A2 (en) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions and methods for altering elastogenesis
CN103458911B (zh) 2011-02-11 2016-02-24 密歇根大学董事会 肽组合物和用于治疗患者的方法
MX2013010977A (es) 2011-03-31 2013-10-30 Procter & Gamble Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica.
JP2015527630A (ja) 2012-06-06 2015-09-17 ザ プロクター アンド ギャンブルカンパニー ヘア／頭皮ケア組成物向け化粧剤の同定システム及び方法
FR3116273B1 (fr) * 2020-11-17 2023-10-27 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR102484277B1 (ko) * 2021-11-22 2023-01-04 대한켐텍 주식회사 피부 미용 개선용 원료 조성물의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (de) * 1997-04-11 1998-10-15 Targor Gmbh Metallocen-Aminosäure- und Peptid-Komplexe
WO1998047921A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1054677B1 (en) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
AU784203B2 (en) * 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides

Also Published As

Publication number Publication date
NZ523403A (en) 2005-04-29
WO2001091700A2 (en) 2001-12-06
EP1392346A4 (en) 2006-10-25
AU2001275018B2 (en) 2008-04-03
NO20030454D0 (no) 2003-01-29
NO20030454L (no) 2003-01-29
IL153687A0 (en) 2003-07-06
EP1392346A2 (en) 2004-03-03
WO2001091700A8 (en) 2003-11-20
AU7501801A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
US6506731B1 (en) Elastin peptide analogs and methods of using same
US10844101B2 (en) Plant-derived elastin binding protein ligands and methods of using the same
RU2441877C2 (ru) Тетрапептид, композиция (варианты) и способ стимуляции продукции коллагена фибробластом
AU2001275018B2 (en) Composition and method for enhancing elasticity of tissue
US7750115B2 (en) Epithelial cell growth promoter
US6794362B1 (en) Asparagine containing elastin peptide analogs
WO2023231573A1 (zh) 肽衍生物异构体及其组合物和用途
AU2001275018A1 (en) Composition and method for enhancing elasticity of tissue
US7666842B2 (en) Elastin peptide analogs and uses thereof
RU2458069C2 (ru) Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
JP4689039B2 (ja) ファゴサイトーシスおよびｉｃａｍ−１発現を調節するための組成物および方法
US6809075B1 (en) Elastin peptide analogs and uses of same incombination with skin enhancing agents
US20230365643A1 (en) Peptide, and cosmetic composition and pharmaceutical composition comprising same
KR101688696B1 (ko) 엔케팔린 변이체를 함유하는 상처 치료용 조성물
AU2003270980A1 (en) Peptide Compositions and Formulations and Use of Same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued